Drug intelligence / Profile preview

4-ethylguaiacol

Development stage
Preclinical
Lead developer
Indiana University
Modality
Small Molecules
Administration
Intraperitoneal, Oral
01

Overview

4-Ethylguaiacol (4-EG) is a naturally occurring phenolic compound found in various foods, including coffee, corn, sesame, and green bell peppers. It is being investigated for its potent anti-inflammatory and neuroprotective properties, particularly in the context of autoimmune diseases like multiple sclerosis (MS). In preclinical models of MS, such as experimental autoimmune encephalomyelitis (EAE), 4-EG has demonstrated the ability to ameliorate disease severity by modulating neuroinflammation. Its mechanism of action involves the induction of Heme Oxygenase-1 (HO-1) expression in the central nervous system (CNS) and in myeloid cells like microglia and macrophages. Furthermore, 4-EG suppresses the activation of microglia, inhibits the differentiation of pathogenic Th1 and Th17 cells, and mitigates blood-brain barrier (BBB) disruption. Due to its ability to attenuate both peripheral and CNS-specific immune responses, it is considered a potential therapeutic candidate for neuroinflammatory disorders.

Other names
4-ethyl-2-methoxyphenolp-ethylguaiacol2-methoxy-4-ethylphenol1-hydroxy-2-methoxy-4-ethylbenzene
02

Targets

HMOX1 (Heme oxygenase 1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on 4-ethylguaiacol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-ethylguaiacol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call